MYRIAD GENETICS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
MYRIAD GENETICS, INC. (MYGN) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$17.70 million for the 12-month period ending 2019-06-30, per its 10-K filed 2019-08-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-08-13
- MYRIAD GENETICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $8.30M, a 38.52% decline year-over-year.
- MYRIAD GENETICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$5.70M, a 165.52% decline year-over-year.
- MYRIAD GENETICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$2.70M, a 437.50% decline year-over-year.
- MYRIAD GENETICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$17.60M.
- MYRIAD GENETICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$17.70M, a 308.24% decline from fiscal 2018.
- MYRIAD GENETICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $8.50M, a 74.93% decline from fiscal 2017.
- MYRIAD GENETICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $33.90M, a 670.45% increase from fiscal 2016.
- MYRIAD GENETICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $4.40M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | $8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $2.60M derived: sum of 2 quarters · filed 2019-08-13 | -$100.00K derived: sum of 3 quarters · filed 2019-08-13 | -$17.70M 10-K · filed 2019-08-13 | ||||
| 2019-03-31 | -$5.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-08 | -$8.40M derived: sum of 2 quarters · filed 2019-05-08 | -$26.00M 10-Q · filed 2019-05-08 | -$12.50M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-12-31 | -$2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | -$20.30M 10-Q · filed 2019-02-06 | -$6.80M derived: sum of 3 quarters · filed 2019-08-13 | $1.90M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-09-30 | -$17.60M 10-Q · filed 2018-11-07 | -$4.10M derived: sum of 2 quarters · filed 2019-08-13 | $4.60M derived: sum of 3 quarters · filed 2019-08-13 | $5.40M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-06-30 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $22.20M derived: sum of 2 quarters · filed 2019-08-13 | $23.00M derived: sum of 3 quarters · filed 2019-08-13 | $8.50M 10-K · filed 2019-08-13 | ||||
| 2018-03-31 | $8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-08 | $9.50M derived: sum of 2 quarters · filed 2019-05-08 | -$5.00M 10-Q · filed 2019-05-08 | -$26.40M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2017-12-31 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | -$13.70M 10-Q · filed 2019-02-06 | -$35.10M derived: sum of 3 quarters · filed 2019-08-13 | -$19.30M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2017-09-30 | -$14.50M 10-Q · filed 2018-11-07 | -$35.90M derived: sum of 2 quarters · filed 2019-08-13 | -$20.10M derived: sum of 3 quarters · filed 2019-08-13 | $1.00M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2017-06-30 | -$21.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | -$5.60M derived: sum of 2 quarters · filed 2019-08-13 | $15.50M derived: sum of 3 quarters · filed 2019-08-13 | $33.90M 10-K · filed 2019-08-13 | ||||
| 2017-03-31 | $15.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $36.90M derived: sum of 2 quarters · filed 2018-05-09 | $55.30M 10-Q · filed 2018-05-09 | $3.30M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-12-31 | $21.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-07 | $39.50M 10-Q · filed 2018-02-07 | -$12.50M derived: sum of 3 quarters · filed 2018-08-24 | -$26.70M derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-09-30 | $18.40M 10-Q · filed 2017-11-08 | -$33.60M derived: sum of 2 quarters · filed 2018-08-24 | -$47.80M derived: sum of 3 quarters · filed 2018-08-24 | -$500.00K derived: sum of 4 quarters · filed 2018-08-24 | ||||
| 2016-06-30 | -$52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | -$66.20M derived: sum of 2 quarters · filed 2018-08-24 | -$18.90M derived: sum of 3 quarters · filed 2018-08-24 | $4.40M 10-K · filed 2018-08-24 | ||||
| 2016-03-31 | -$14.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-03 | $33.10M derived: sum of 2 quarters · filed 2017-05-03 | $56.40M 10-Q · filed 2017-05-03 | $65.30M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-12-31 | $47.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | $70.60M 10-Q · filed 2017-02-08 | $79.50M derived: sum of 3 quarters · filed 2017-08-09 | $75.00M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-09-30 | $23.30M 10-Q · filed 2016-11-02 | $32.20M derived: sum of 2 quarters · filed 2017-08-09 | $27.70M derived: sum of 3 quarters · filed 2017-08-09 | $17.60M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-06-30 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $4.40M derived: sum of 2 quarters · filed 2017-08-09 | -$5.70M derived: sum of 3 quarters · filed 2017-08-09 | -$700.00K 10-K · filed 2017-08-09 | ||||
| 2015-03-31 | -$4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-04 | -$14.60M derived: sum of 2 quarters · filed 2016-05-04 | -$9.60M 10-Q · filed 2016-05-04 | -$9.61M 10-Q · filed 2015-05-06 | -$30.63M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-12-31 | -$10.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-03 | -$5.10M 10-Q · filed 2016-02-03 | -$5.11M 10-Q · filed 2015-02-04 | -$26.13M derived: sum of 3 quarters · filed 2016-08-10 | -$11.93M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-09-30 | $5.00M 10-Q · filed 2015-11-04 | $4.98M 10-Q · filed 2014-11-05 | -$16.02M derived: sum of 2 quarters · filed 2016-08-10 | -$1.83M derived: sum of 3 quarters · filed 2016-08-10 | -$15.21M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-06-30 | -$21.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | -$6.83M derived: sum of 2 quarters · filed 2016-08-10 | -$20.21M derived: sum of 3 quarters · filed 2016-08-10 | -$39.30M 10-K · filed 2016-08-10 | -$39.25M 10-K · filed 2014-08-13 | |||
| 2014-03-31 | $14.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $811.00K derived: sum of 2 quarters · filed 2015-05-06 | -$18.27M 10-Q · filed 2015-05-06 | -$26.55M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-12-31 | -$13.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-04 | -$32.47M 10-Q · filed 2015-02-04 | -$40.74M derived: sum of 3 quarters · filed 2015-08-12 | $3.15M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-09-30 | -$19.09M 10-Q · filed 2014-11-05 | -$27.36M derived: sum of 2 quarters · filed 2015-08-12 | $16.54M derived: sum of 3 quarters · filed 2015-08-12 | -$10.62M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-06-30 | -$8.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $35.63M derived: sum of 2 quarters · filed 2015-08-12 | $8.47M derived: sum of 3 quarters · filed 2015-08-12 | $17.70M 10-K · filed 2015-08-12 | $17.72M 10-K · filed 2013-08-14 | |||
| 2013-03-31 | $43.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $16.74M derived: sum of 2 quarters · filed 2014-05-07 | $25.97M 10-Q · filed 2014-05-07 | $7.47M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-12-31 | -$27.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | -$17.93M 10-Q · filed 2014-02-05 | -$36.43M derived: sum of 3 quarters · filed 2014-08-13 | -$40.42M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-09-30 | $9.23M 10-Q · filed 2013-11-12 | -$9.27M derived: sum of 2 quarters · filed 2014-08-13 | -$13.27M derived: sum of 3 quarters · filed 2014-08-13 | $32.91M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-06-30 | -$18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | -$22.50M derived: sum of 2 quarters · filed 2014-08-13 | $23.68M derived: sum of 3 quarters · filed 2014-08-13 | $33.67M 10-K · filed 2014-08-13 | ||||
| 2012-03-31 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $42.18M derived: sum of 2 quarters · filed 2013-05-08 | $52.17M 10-Q · filed 2013-05-08 | $37.47M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-12-31 | $46.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-06 | $56.17M 10-Q · filed 2013-02-06 | $41.47M derived: sum of 3 quarters · filed 2013-08-14 | $41.18M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-09-30 | $9.99M 10-Q · filed 2012-11-09 | -$4.70M derived: sum of 2 quarters · filed 2013-08-14 | -$4.99M derived: sum of 3 quarters · filed 2013-08-14 | -$60.63M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-06-30 | -$14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | -$14.99M derived: sum of 2 quarters · filed 2013-08-14 | -$70.62M derived: sum of 3 quarters · filed 2013-08-14 | -$40.16M 10-K · filed 2013-08-14 | ||||
| 2011-03-31 | -$291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-02 | -$55.93M derived: sum of 2 quarters · filed 2012-05-02 | -$25.46M 10-Q · filed 2012-05-02 | -$34.77M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-12-31 | -$55.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-01 | -$25.17M 10-Q · filed 2012-02-01 | -$34.48M derived: sum of 3 quarters · filed 2012-08-15 | $7.24M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-09-30 | $30.46M 10-Q · filed 2011-11-02 | $21.16M derived: sum of 2 quarters · filed 2012-08-15 | $62.87M derived: sum of 3 quarters · filed 2012-08-15 | $32.11M derived: sum of 4 quarters · filed 2012-08-15 | ||||
| 2010-06-30 | -$9.31M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-15 | $32.41M derived: sum of 2 quarters · filed 2012-08-15 | $1.64M derived: sum of 3 quarters · filed 2012-08-15 | $29.33M 10-K · filed 2012-08-15 | ||||
| 2010-03-31 | $41.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-05-04 | $10.95M derived: sum of 2 quarters · filed 2011-05-04 | $38.64M 10-Q · filed 2011-05-04 | |||||
| 2009-12-31 | -$30.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-02-01 | -$3.08M 10-Q · filed 2011-02-01 | ||||||
| 2009-09-30 | $27.69M 10-Q · filed 2010-11-03 | |||||||
| 2009-06-30 | -$174.22M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |